Onconase (ONC) a ribonuclease from amphibian oocytes is cytostatic and
cytotoxic to many human tumor lines, shows in vivo antitumor activity
in mouse tumor models and is in Phase UI clinical trials. The mechani
sm of antitumor activity of ONC is presumed to be due to its internali
zation, degradation of intracellular RNA and suppression of protein sy
nthesis. Since apoptosis triggered by TNF-alpha is known to be potenti
ated by inhibitors of protein synthesis, we have hypothesized that it
also may be potentiated by ONC. Indeed, preincubation of U-937 or HL-6
0 leukemic cells with 0.17 mu M ONC rendered them more sensitive to in
duction of apoptosis by TNF-alpha or antibody to CD95 (Fas). The mecha
nism by which ONC amplifies the effect of TNF-alpha may involve suppre
ssion of induction of the survival genes whose expression is triggered
by activation of NF kappa B by this factor.